Key result
CSRP3 L44P mutation disrupts LIM1 domain core and secondary structure in molecular simulations.
Why the study?
Experimentally verifying every reported mutation in CSRP3 LIM domains is challenging in time and resources, necessitating a rapid in-silico screening method.
A novel in-silico virtual mutagenesis screening method provides structural rationale for how specific CSRP3 mutations contribute to dilated and hypertrophic cardiomyopathies.
May guide CSRP3 variant prioritization in research; leaves open clinical adoption pending functional and cohort validation.
Cardiomyopathies are a severe and chronic cardiovascular burden worldwide, affecting a large cohort in the general population. Cysteine and glycine-rich protein 3 (CSRP3) is one of key proteins implicated in dominant dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). In this study, we device a rapid in-silico screening protocol that creates a mutational landscape map for all possible allowed and disallowed substitutions in the protein of interest. This map provides the structural and functional insights on the stability of LIM domains of CSRP3. Further, the sequence analysis delineates the eukaryotic CSRP3 protein orthologs which complements the mutational map. Next, we also evaluated the effect of HCM/DCM mutations on these domains. One of highly destabilising mutations - L44P (also disease causing) and a neutral mutation - L44M were further subjected to molecular dynamics (MD) simulations. The results establish that L44P substitution affects the LIM domain structure. The present study provides a useful perspective to our understanding of the role of mutations in the CSRP3 LIM domains and their evolution. Experimentally verifying every reported mutation can become challenging both in time and resources used. This study provides a novel screening method for quick identification of key mutation sites for specific protein structures that can reduce the burden on experimental research.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2021) studied Cardiomyopathy. Virtual mutagenesis vs. Wild-type CSRP3 was evaluated on Protein structural stability (ΔΔG) and molecular dynamics. Comprehensive virtual mutagenesis and molecular dynamics simulations demonstrated that the L44P mutation in CSRP3 disrupts the LIM1 domain's hydrophobic core and secondary structure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: